Menu Search
Equities

Meilleure Health International Industry Group Ltd

2327:HKG.HZ

Meilleure Health International Industry Group Ltd

Actions
  • Price (HKD)0.165
  • Today's Change-0.003 / -1.79%
  • Shares traded954.00k
  • 1 Year change-37.74%
  • Beta--
Data delayed at least 15 minutes, as of May 09 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Meilleure Health International Industry Group Limited is an investment holding company principally engaged in the trading of health care products, chemical materials and building materials. The Company operates its business through five segments. The Trading of Health Care Products, Chemical Materials and Building Materials segment is engaged in the trading of health care products, chemical materials and building materials. The Research and Development segment is engaged in the research and development of chemical and biological products. The Investment and Treasury Function segment is engaged in investment holding and treasury function. The Consultancy and Agency Business segment is engaged in the provision of property agency and consultancy service. The Property Development segment is engaged in the development of residential properties.

  • Revenue in HKD (TTM)129.30m
  • Net income in HKD40.83m
  • Incorporated2002
  • Employees57.00
  • Location
    Meilleure Health International Industry Group LtdUnit 2906, Tower 1, Lippo Centre89 QueenswayAdmiralty Hong KongHKG
  • Phone+852 25631500
  • Fax+852 25631900
  • Websitehttp://www.meilleure.com.cn
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		2327:HKG since
announced		Transaction
value
Suzhou Yurun Real Estate Co Ltd-Real EstateAnnounced17 Oct 202317 Oct 2023Announced-38.52%4.94m
Data delayed at least 15 minutes, as of May 10 2024 08:59 BST.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.